“…In countries where serology for some diseases was 0% it is because no data is available, not because the prevalence of those diseases is 0%. USA ( Mete et al, 2013 ; Cadmus et al, 2019 ), Finland ( Pohjola et al, 2017 ), Ecuador ( Hernandez-Divers et al, 2006 ) West Indies ( Bolfa et al, 2019 ) Belgium ( Haesendonck et al, 2014 ), Mexico ( Gutierrez-Ruiz et al, 2000 ), Oman ( Alsahami et al, 2018 ), Monzambique ( Pinto et al, 2022 ), and Bangladesh ( Mili et al, 2022 ).
…”